@GastroAGI

1 Followers
21 Following
59 Posts

• A standard drink (SD) contains approximately 14 grams (0.6 fl oz) of pure alcohol
• Different beverages contain the same amount of alcohol but in different volumes
• This is due to variation in alcohol concentration (ABV – Alcohol by Volume)

#AlcoholAwareness #StandardDrink #PublicHealth #PreventiveMedicine #HealthEducation #MedED

🔬 Biopsy smart, not routine.

Knowing when to biopsy—and when not to— can change diagnosis, management, and outcomes in upper GI endoscopy.

From Barrett’s protocols to linitis plastica sampling—precision matters.

#GastroAGI #Endoscopy #UpperGI #Biopsy #Gastroenterology #GIEndoscopy #MedicalEducation

🎯 HCC treatment is evolving…
TACE + immunotherapy + targeted therapy shows stronger outcomes—but are we ready to change practice?

⚠️ Promising data, but guidelines still need phase III confirmation

#GastroAGI #HCC #LiverCancer #TACE #Immunotherapy #TargetedTherapy #Hepatology #Oncology #MedEd

New updates in gastroenterology from ECCO 2026.

20+ Latest Topics From Conference

Explore more:

https://gastroagi.com

New updates in gastroenterology from CDDW 2026.

Topics include the gut microbiome, bacterial therapeutics in colorectal cancer, helminth-immune modulation in IBD, gut mycobiome, and microbiome roles in MASLD progression.

Explore more:
https://gastroagi.com

#Gastroenterology #GutMicrobiome #CDDW2026 #MedEd

CT chest shows a markedly dilated, fluid-filled oesophagus with smooth distal tapering and no obstructing mass—imaging features suggestive of achalasia.

Diagnosis confirmed on high-resolution manometry (Type II).

Patient underwent POEM, with dysphagia score improving
from 3 → 1.

📌 A nice example of radiology–manometry–endoscopy concordance and clinical response.

#Achalasia #POEM #Gastroenterology #Manometry #GastroAGI

Nutrition is central in cirrhosis care. Malnutrition, sarcopenia, and frailty worsen transplant outcomes.

Early assessment, adequate calories, and high-quality protein prehabilitation preserve muscle and resilience. The waitlist is a window to intervene.

#Cirrhosis #Hepatology #TransplantMedicine #NutritionInCirrhosis #Sarcopenia #MedicalEducation #EvidenceBasedMedicine #GastroAGI

GastroAGI is an AI-powered knowledge platform for gastroenterology & hepatology—built for clinicians, trainees, and researchers.

Evidence-first answers from journals, guidelines, and conferences. No noise. No hallucinations. Just clarity.

#GastroAGI #Gastroenterology #Hepatology #MedicalAI #EvidenceBasedMedicine #MedEd #ClinicalPractice #GIResearch

miR147 protects gut mucosa by strengthening epithelial integrity and controlling inflammation.

Knockout → severe colitis, barrier loss, ↑ permeability.

miR147 targets Ndufa4 to maintain metabolic balance + type I IFN signaling.

Therapeutic potential in IBD & colorectal cancer.

#GastroAGI #IBD #MicroRNA #GutHealth

COBALT Trial (PBC): Despite early termination, adjusted analyses + real-world external controls showed obeticholic acid (OCA) reduces major liver events.

EC (External Control) analysis: 60% risk reduction in the risk of adverse clinical outcomes like death, liver transplantation, or hepatic decompensation.(HR 0.39).

Well-tolerated; pruritus most common.

Highlights power of hybrid RCT + real-world evidence.

#PBC #Hepatology #GastroAGI